The mechanisms of 6-hydroxydopamine-induced astrocyte death

Ann N Y Acad Sci. 2005 Jun:1048:400-5. doi: 10.1196/annals.1342.049.

Abstract

Treatment with 6-hydroxydopamine significantly reduced the viability of cultured rat primary astrocytes, rat astrocytoma cell line C6, and human astrocytoma cell line U251. 6-Hydroxydopamine-treated astrocytes exhibited altered nuclear morphology, DNA fragmentation, and reduced intracellular esterase activity, which indicated apoptotic cell death. Astrocytes were protected by neutralization of 6-hydroxydopamine autooxidation products H(2)O(2), O(2)(*-), and (*)OH, but not by cell-derived or chemically generated anti-apoptotic free radical nitric oxide. Finally, 6-hydroxydopamine activated extracellular signal-regulated kinase in astrocytes and selective inhibitor of extracellular signal-regulated kinase activation partially prevented astrocyte death. Taken together, these data indicate that 6-hydroxydopamine-triggered oxidative stress induces extracellular signal-regulated kinase-dependent apoptotic death of astrocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agents / pharmacology
  • Animals
  • Astrocytes / cytology
  • Astrocytes / drug effects*
  • Astrocytes / ultrastructure
  • Cell Death / drug effects
  • Cells, Cultured
  • DNA Fragmentation / drug effects*
  • Dose-Response Relationship, Drug
  • Esterases / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Free Radicals / metabolism
  • Humans
  • Nitric Oxide / metabolism
  • Oxidative Stress / drug effects*
  • Oxidopamine / toxicity*
  • Rats
  • Time Factors

Substances

  • Adrenergic Agents
  • Free Radicals
  • Nitric Oxide
  • Oxidopamine
  • Extracellular Signal-Regulated MAP Kinases
  • Esterases